CHINA NATIONAL MEDICINES CORPORATION LTD.

Andere talen China National Medicines Corporation Ltd.

Aandelen

600511

CNE000001D56

slotkoers Shanghai S.E. Andere beurzen 00:00:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
34,83 ^CNY	+0,55%		-1,55%	+21,70%

21/03	Chinese aandelen sloten gedempt terwijl optimisme over herstel wegebt; Sinopharm springt met 6% na positieve winst voor 2023	MT
21/03	Winst Sinopharm in 2023 stijgt met 9%; aandelen stijgen met 6%	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings	21/03
Sinopharm's 2023 Profit Climbs 9%; Shares Up 6%	21/03
China National Medicines Corporation Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
China National Medicines Deputy Manager Under Probe for Alleged Insider Trading	10/01
CASI Pharmaceuticals, Inc. Enters into an Exclusive Distribution Agreement with China National Medicines Corporation Ltd	08/12
China National Medicines' Profit Drops 16.1% in Q3	25-10-23
China National Medicines Corporation Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24-10-23
Sinopharm CFO Retires; Successor Named	16-10-23
China National Medicines Corporation Ltd.(XSSC:600511) added to S&P Global BMI Index	18-09-23
China National Medicines Corporation Ltd.(XSSC:600511) added to FTSE All-World Index	18-09-23
China National Medicines' Profit Climbs 14.2% in H1	24-08-23
China National Medicines Corporation Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23
China National Medicines' Q1 Profit Rises 10.9%	26-04-23
China National Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25-04-23
Sinopharm’s Profit Rises 12% in 2022; Revenue Slips 2%	23-03-23
China National Medicines' 2022 Profit Up 12%	23-03-23
Sinopharm Eyes Production of Merck's COVID-19 Drug in China	13-01-23
Sinopharm Clarifies It Is Not A Distributor for Pfizer's COVID-19 Drug	20-12-22
Sinopharm to Buy $168 Million Shares in Shyndec Pharma	30-11-22
Sinopharm Unit Wins Nod to Launch Clinical Trial of COVID-19 Nasal Drug	30-11-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen China National Medicines Corporation Ltd.

Aandelen

600511

CNE000001D56

Andere talen

Filters